Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q79165387)
Watch
English
Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response
scientific article published on 01 October 2006
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17012049
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012049%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 December 2019
title
Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17012049
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012049%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 December 2019
author name string
Robin L Jones
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17012049
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012049%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 December 2019
Ian E Smith
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17012049
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012049%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 December 2019
publication date
1 October 2006
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17012049
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012049%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 December 2019
published in
Lancet Oncology Commission
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17012049
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012049%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 December 2019
volume
7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17012049
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012049%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 December 2019
issue
10
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17012049
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012049%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 December 2019
page(s)
869-874
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17012049
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012049%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 December 2019
cites work
Is there still a role for neoadjuvant therapy in breast cancer?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970906-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1470-2045(06)70906-8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17012049
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012049%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 December 2019
PubMed publication ID
17012049
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17012049
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012049%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit